Gut Microbiome-Metabolome Profiling in H. Pylori-SIBO Comorbidity | MicrobiomeTrials← Back to trialsNCT07122284
Gut Microbiome-Metabolome Profiling in H. Pylori-SIBO Comorbidity
CompletedOBSERVATIONAL
Trial Details
Start: 2024-01-31Est. Completion: 2024-12-30
Enrollment target: 42 participants Locations- Zhongshan Hospital (Xiamen), Fudan University, Xiamen, Fujian, China
Other microbiome trials you might be interested in
Type 2 DiabetesDiabetes Mellitus Type 2
AIM-MET is a randomized clinical study testing whether a fixed microbiome-targeted nutritional product can improve blood…
Izmir, Turkey (Türkiye)Est. completion Mar 30, 2027
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
The goal of this clinical trial is to understand how gallotannin-rich (GT-rich) mangoes can reduce the inflammatory mark…
Prairie View, United StatesEst. completion Jun 2026